These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25713362)

  • 1. Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function.
    Lakhal-Littleton S; Wolna M; Carr CA; Miller JJ; Christian HC; Ball V; Santos A; Diaz R; Biggs D; Stillion R; Holdship P; Larner F; Tyler DJ; Clarke K; Davies B; Robbins PA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3164-9. PubMed ID: 25713362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
    Lakhal-Littleton S; Wolna M; Chung YJ; Christian HC; Heather LC; Brescia M; Ball V; Diaz R; Santos A; Biggs D; Clarke K; Davies B; Robbins PA
    Elife; 2016 Nov; 5():. PubMed ID: 27897970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.
    Donovan A; Lima CA; Pinkus JL; Pinkus GS; Zon LI; Robine S; Andrews NC
    Cell Metab; 2005 Mar; 1(3):191-200. PubMed ID: 16054062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload.
    Mohammad G; Matakidou A; Robbins PA; Lakhal-Littleton S
    Kidney Int; 2021 Sep; 100(3):559-569. PubMed ID: 33991530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice.
    Ledesma-Colunga MG; Baschant U; Fiedler IAK; Busse B; Hofbauer LC; Muckenthaler MU; Altamura S; Rauner M
    Bone; 2020 Aug; 137():115400. PubMed ID: 32380257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
    Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological functions of ferroportin in the regulation of renal iron recycling and ischemic acute kidney injury.
    Wang X; Zheng X; Zhang J; Zhao S; Wang Z; Wang F; Shang W; Barasch J; Qiu A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1042-F1057. PubMed ID: 29923765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambient fine particulate matter aggravates atherosclerosis in apolipoprotein E knockout mice by iron overload via the hepcidin-ferroportin axis.
    Wan Q; Yang M; Liu Z; Wu J
    Life Sci; 2021 Jan; 264():118715. PubMed ID: 33160991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin regulates intrarenal iron handling at the distal nephron.
    Moulouel B; Houamel D; Delaby C; Tchernitchko D; Vaulont S; Letteron P; Thibaudeau O; Puy H; Gouya L; Beaumont C; Karim Z
    Kidney Int; 2013 Oct; 84(4):756-66. PubMed ID: 23615502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin.
    Gammella E; Correnti M; Cairo G; Recalcati S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights into the Hepcidin-Ferroportin Axis and Iron Homeostasis in iPSC-Derived Cardiomyocytes from Friedreich's Ataxia Patient.
    Bolotta A; Abruzzo PM; Baldassarro VA; Ghezzo A; Scotlandi K; Marini M; Zucchini C
    Oxid Med Cell Longev; 2019; 2019():7623023. PubMed ID: 31049138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice overexpressing hepcidin suggest ferroportin does not play a major role in Mn homeostasis.
    Jin L; Frazer DM; Lu Y; Wilkins SJ; Ayton S; Bush A; Anderson GJ
    Metallomics; 2019 May; 11(5):959-967. PubMed ID: 30888356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation.
    Jiang L; Wang J; Wang K; Wang H; Wu Q; Yang C; Yu Y; Ni P; Zhong Y; Song Z; Xie E; Hu R; Min J; Wang F
    Blood; 2021 Aug; 138(8):689-705. PubMed ID: 33895792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ferroportin polymorphism on iron homeostasis and infection.
    Kasvosve I
    Clin Chim Acta; 2013 Feb; 416():20-5. PubMed ID: 23178444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin.
    De Domenico I; Lo E; Yang B; Korolnek T; Hamza I; Ward DM; Kaplan J
    Cell Metab; 2011 Nov; 14(5):635-46. PubMed ID: 22019085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice with hepcidin-resistant ferroportin accumulate iron in the retina.
    Theurl M; Song D; Clark E; Sterling J; Grieco S; Altamura S; Galy B; Hentze M; Muckenthaler MU; Dunaief JL
    FASEB J; 2016 Feb; 30(2):813-23. PubMed ID: 26506980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal liver hepcidin secures iron stores in utero.
    Kämmerer L; Mohammad G; Wolna M; Robbins PA; Lakhal-Littleton S
    Blood; 2020 Sep; 136(13):1549-1557. PubMed ID: 32542311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper deficiency has minimal impact on ferroportin expression or function.
    Prohaska JR; Broderius M
    Biometals; 2012 Aug; 25(4):633-42. PubMed ID: 22294464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.
    Zhang DL; Ghosh MC; Ollivierre H; Li Y; Rouault TA
    Blood; 2018 Nov; 132(19):2078-2087. PubMed ID: 30213870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult mice.
    Winn NC; Wolf EM; Cottam MA; Bhanot M; Hasty AH
    Am J Physiol Endocrinol Metab; 2021 Sep; 321(3):E376-E391. PubMed ID: 34338042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.